Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival
以表观遗传为重点的 CRISPR/Cas9 筛选确定 (缺失、小或同源)2 样蛋白 (ASH2L) 是胶质母细胞瘤细胞存活的调节剂
期刊:Cell Communication and Signaling
影响因子:8.2
doi:10.1186/s12964-023-01335-6
Ezgi Ozyerli-Goknar, Ezgi Yagmur Kala, Ali Cenk Aksu, Ipek Bulut, Ahmet Cingöz, Sheikh Nizamuddin, Martin Biniossek, Fidan Seker-Polat, Tunc Morova, Can Aztekin, Sonia H Y Kung, Hamzah Syed, Nurcan Tuncbag, Mehmet Gönen, Martin Philpott, Adam P Cribbs, Ceyda Acilan, Nathan A Lack, Tamer T Onder, H T